ArticleNeuromuscular disorders : NMD2016

Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.

Eugenio Mercuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.